UBS raised the firm’s price target on Varonis to $38 from $35 and keeps a Buy rating on the shares. Q3 was a step in the right direction, with Varonis beating on ARR growth, free cash flow, and SaaS mix, and the guidance for Q4 looks conservative, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VRNS: